Nancy M. Lincé, RAC

Nancy M. Lincé is a medical device executive with more than 30 years of industry experience. As Founder and CEO of Lincé Consulting, she has advised emerging and established medical technology companies for more than 25 years on regulatory strategy, clinical development, quality systems, and product development. Her experience spans U.S. and global regulatory pathways, including 510(k), De Novo, IDE, and PMA submissions, European Design Dossiers and Technical Documentation, CE Marking, and other international market applications. Nancy also serves as an advisor to the Stanford Innovative Biodesign and Albert Einstein innovation programs, providing regulatory, clinical and commercialization guidance to emerging medical technology innovators.